Telotristat, Catalog: B338

IN STOCK!
US$0.00

P778902 4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine

PRODUCT SUMMARY

Alternate Names P778902 4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine

Appearance Solid

CAS # 1033805-28-5

Molecular Formula C₂₅H₂₂ClF₃N₆O₃

Molecular Weight 546.9

Purity ≥ 98%

Solubility ~10 mg/ml DMSO

SMILES NC1=NC(C2=CC=C(C[C@H](N)C(O)=O)C=C2)=CC(O[C@H](C3=CC=C(Cl)C=C3N4C=CC(C)=N4)C(F)(F)F)=N1

InChi InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1

InChi Key NCLGDOBQAWBXRA-PGRDOPGGSA-N

Storage Conditions -20ºC

Shipping Conditions Gel Pack

Usage For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear gloves and a mask when handling the product! Avoid contact by all modes of exposure.

DESCRIPTION

Telotristat is an oral, small molecule inhibitor of tryptophan hydroxylase 1 (TPH1) IC50 = 16 nM) that is used in the treatment of symptoms of carcinoid syndrome. By inhibiting this enzyme, telotristat reduces the synthesis of serotonin in the body, thereby alleviating the symptoms of carcinoid syndrome.